News
Why US-EU trade deal faces jeopardy over ambiguous pharmaceutical tariffs
Pharmaceutical companies are seeking clarification on tariffs imposed under the new US-EU trade agreement . Analysts caution that sector-specific punitive levies could jeopardise the entire deal, according to a CNBC report.
The benchmark STOXX 600 rose 0.9% to hit a four-month high early in Monday's session but reversed course to close about 0.2% ...
US President Donald Trump announced on Sunday that the United States was imposing 15-percent tariffs on all European Union ...
Despite being significantly lower than the 200% rate threatened by Trump, the deal is set to ramp up drug costs by billions.
Stellantis said on Tuesday it faced greater headwinds this year including a 1.5-billion-euro impact from U.S. tariffs for ...
Tuko on MSN3h
Philips chops back US tariff billDutch medical equipment manufacturer Philips said Tuesday that the impact of US tariffs would be much less than it initially estimated, sending its share price surging.It said Tuesday it now expects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback